Skip to main content

BGI Genomics enhances NIFTY prenatal testing package with DNBSEQ-G99 platform for sooner and correct outcomes

BGI Europe A/S, a completely owned subsidiary of BGI Genomics, introduced its NIFTY® non-invasive prenatal testing package and software program (CE-IVDD Record B) have been granted an extension beneath its present CE-IVDD certification to incorporate the DNBSEQ-G99 mannequin to fulfill the European Union rules for medical units.

In January 2024, BGI Genomics unveiled the NIFTY® ultra-fast non-invasive prenatal genetic testing product, using the progressive DNBSEQ-G99 platform. Designed for each small and medium throughput, this platform ensures top-notch testing efficiency and high quality. It allows scientific laboratories to supply faster and extra correct prenatal genetic testing outcomes. This development is essential for well timed genetic counseling and additional prenatal analysis, enhancing prenatal care choices.

Key options of the DNBSEQ-G99 platform:

Pace: The DNBSEQ-G99 platform dramatically reduces sequencing time to simply 3 hours, with your complete course of from pattern assortment to report era taking solely 14 hours. This effectivity considerably reduces the anxious look ahead to anticipating households.

Flexibility: It permits for the processing of various pattern sizes in a single run, accommodating a minimal of 12 samples. This flexibility helps in minimizing reagent waste and chopping prices.

Versatility: The platform helps varied sequencing modes and is appropriate for a variety of assessments, together with pre-embryo transplantation chromosome testing and monogenic illness provider screening.

Simplicity: That includes a cassette move cell and an progressive pre-injected reagent design, the DNBSEQ-G99 simplifies the sequencing course of, making it user-friendly for operators.

BGI Genomics has been a pioneer in non-invasive prenatal genetic testing since 2010. NIFTY® has acquired medical machine {qualifications} in varied nations, together with the UK, Australia, Saudi Arabia, Turkey, India, and Thailand. BGI Genomics continues to improve its prenatal and neonatal assessments, contributing to higher public well being techniques and outcomes.

Guided by the imaginative and prescient of “Omics for all,” BGI Genomics is devoted to enhancing genetic testing applied sciences, thereby advancing world precision drugs and enhancing lives.


Supply hyperlink

Hector Antonio Guzman German

Graduado de Doctor en medicina en la universidad Autónoma de Santo Domingo en el año 2004. Luego emigró a la República Federal de Alemania, dónde se ha formado en medicina interna, cardiologia, Emergenciologia, medicina de buceo y cuidados intensivos.

Leave a Reply